This episode: Engineered bacteria could help people digest an essential nutrient when they can't digest it themselves!
Download Episode (8.5 MB, 9.3 minutes) Show notes: Microbe of the episode: Kadipiro virus News item (paywall) Science-Based Medicine blog article about phenylketonuria, Synlogic, and engineering bacteria to treat this disorder, with lots of good detail Takeaways Treating genetic disorders can be very difficult. Sometimes they can be managed, with lifestyle, diet, or medication, but cure has almost always been out of the picture. With a disorder such as phenylketonuria (PKU), for example, in which the body is unable to fully metabolize the amino acid phenylalanine, diet and medication may work to some extent. In an effort to provide better options for PKU, scientists at Synlogic, Inc have created a strain of Escherichia coli that produces phenylalanine-degrading enzymes in the gut. The hope is that ingesting this bacterium could allow PKU patients to be less restrictive with their diet. Journal Paper: Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA, Reeder PJ, Momin MM, Bergeron CG, Guilmain SE, Miller PF, Kurtz CB, Falb D. 2018. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol 36:857–864.
Other interesting stories:
Email questions or comments to bacteriofiles at gmail dot com. Thanks for listening!
Subscribe: Apple Podcasts, RSS, Google Play. Support the show at Patreon, or check out the show at Twitter or Facebook